Analytical Treatment Interruption in HIV Trials: Statistical and Study Design Considerations.

Journal Information

Full Title: Curr HIV/AIDS Rep

Abbreviation: Curr HIV/AIDS Rep

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Acquired Immunodeficiency Syndrome

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Conflicts of InterestThe authors declare no competing interests. Human and Animal RightsThis article does not contain any studies with human or animal subjects performed by any of the authors. Conflicts of Interest The authors declare no competing interests."

Evidence found in paper:

"Funding This work was supported in part by AIDS Clinical Trials Group funded by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Number UM1 AI068634 and UM1 AI068636, by Combined Immunologic Approaches to Cure HIV-1 funded under Award Number UM1 AI126603 and by the Statistical and Data Management Center of the International Maternal Pediatric Adolescent AIDS Clinical Trials Network under the National Institute of Allergy and Infectious Diseases grant No. UM1 AI068616."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025